Colfax Corporation to Acquire Mathys AG Bettlach

DJO is expanding its joint reconstruction footprint outside of the United States.

The subsidiary’s parent company, Colfax Corporation, is acquiring Mathys AG Bettlach, a Switzerland-based company that develops and distributes products for artificial joint replacement, synthetic bone graft solutions, and sports medicine. The transaction is expected to close in Q3, subject to receipt of applicable regulatory approvals and the satisfaction of other closing conditions.

“We are very pleased by this opportunity to enlarge our successful reconstructive product portfolio with Mathys’ complementary surgical solutions and customer base, and even more excited about our ability to quickly advance our collective orthopedic leadership outside of the United States,” said Brady Shirley, CEO of DJO. “Mathys’ differentiated products, deep expertise and talented global team will help us accelerate our strategic imperative of delivering superior patient outcomes around the world.”
 
The addition of Mathys will add a successful channel outside of the U.S. for DJO’s joint replacement products, including the clinically proven AltiVate Reverse® shoulder replacement system,ⁱ EMPOWR Hip and Knee Systems, and its foot and ankle solutions. The acquisition is also expected to strengthen DJO’s patient-focused innovation pipeline and broaden its reconstructive portfolio with the complementary addition of many clinically proven surgical solutions from Mathys,^ii,iii including its RM Pressfit Vitamys Monobloc acetabular cup. 
 
Founded in 1946 and driven by the preservation of mobility, Mathys is an international orthopedics leader with production sites in Switzerland and Germany along with sales and service subsidiaries in Europe and Asia. The two businesses look forward to integrating their technology and capabilities for increased efficiencies, improved clinical outcomes and optimized marketing opportunities.
 
“Combining these two leading orthopedic businesses into one global platform creates an exciting opportunity to build on the strengths of both Mathys and DJO in developing and delivering the next generation of orthopedic innovations,” said Dr. Benjamin Reinmann, CEO of Mathys. “I believe that our employees, customers and their patients will benefit from this combination which will create even greater opportunities for growth and continued success.”

References
ⁱ Cuff et al. Reverse shoulder arthroplasty for the treatment of rotator cuff deficiency: a concise follow-up, at a minimum of 10 years, of previous reports. Journal of Bone and Joint Surgery. 2017
ⁱⁱ Ihle, M., et al., The results of the titanium-coated RM acetabular component at 20 years: a long-term follow-up of an uncemented primary total hip replacement. J Bone Joint Surg Br, 2008. 90(10): p. 1284-90.
ⁱⁱⁱ Pakvis, D.B., L.;van Hellemondt, G.;Spruit, M., A cementless elastic monoblock socket in young patients: a ten to 18-year clinical and radiological follow-up. Int Orthop, 2011. 35(10): p. 1445-51.